Physician profile
Michael J Ewing
NPI 1053708784
$450,243.05
in general payments reported to CMS, 2019-2025
17 companies · $190K in 2025
The $190K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.27 · 2020: $191 · 2021: $19K · 2022: $82K · 2023: $50K · 2024: $109K · 2025: $190K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $229K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $49K · Travel and Lodging: $39K · Food and Beverage: $20K · Consulting Fee: $12K · Gift: $23.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $228,600.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $48,500.00 |
| Travel and Lodging | $39,497.33 |
| Food and Beverage | $20,398.30 |
| Consulting Fee | $11,900.00 |
| Gift | $23.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $417,587.47 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Integra Lifesciences Corporation | $26,005.08 | 2020-2025 | Integra, Omnigraft, Durasorb Monofilament Mesh |
| Davol INC. | $2,337.91 | 2021-2025 | Phasix Mesh |
| Medical Device Business Services, INC. | $1,362.36 | 2025 | Linx Reflux Management System |
| Stryker Corporation | $1,208.94 | 2021-2025 | Pangea |
| Ethicon US, LLC | $534.56 | 2021-2025 | Megadyne, Linx Reflux Management System, Enseal |
| Tela Bio, INC. | $330.97 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Kerecis Limited | $232.88 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Boston Scientific Corporation | $203.79 | 2025 | Spyglass, Spyglass Discover |
| Medtronic, INC. | $164.54 | 2022-2025 | Progrip, Emprint |
| Sirius Medical Systems | $68.91 | 2024 | Pintuition |
| Conmed Corporation | $68.15 | 2022-2023 | Airseal |
| Smith+Nephew, INC. | $40.30 | 2023 | Pico |
| Mesh Suture INC | $35.67 | 2025 | |
| W. L. Gore & Associates, INC. | $31.88 | 2024 | Gore Enform Preperitoneal Biomaterial |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $15.86 | 2022 | |
| Inari Medical, INC. | $13.78 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Ewing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.